EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders

Ahmed M Abu El-Asrar iD, Gert De Hertogh, Eef Allegaert, Mohd I Nawaz iD, Sara Abouelasrar Salama iD, Priscilla W Gikandi, Ghislain Opdenakker iD, Sofie Struyf iD

International Journal of Molecular Sciences · 31.08.2023 · 24 (17) · 13510

DOI: 10.3390/ijms241713510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.08.2023. Verfasst von Ahmed M Abu El-Asrar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia. Hauptthemen laut MEDLINE: Epiretinal Membrane, Eye Diseases, Diabetic Retinopathy, Vitreoretinopathy, Proliferative. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia, C1 funding, Research Foundation of Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and fibrosis are key features of proliferative vitreoretinal disorders. We aimed to define the macrophage phenotype and investigate the role of macrophage-myofibroblast transition (MMT) in the contribution to myofibroblast populations present in epiretinal membranes. Vitreous samples from proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR) and nondiabetic control patients, epiretinal fibrovascular membranes from PDR patients and fibrocellular membranes from PVR patients, human retinal Müller glial cells and human retinal microvascular endothelial cells (HRMECs) were studied by ELISA, immunohistochemistry and flow cytometry analysis. Myofibroblasts expressing α-SMA, fibroblast activation protein-α (FAP-α) and fibroblast-specific protein-1 (FSP-1) were present in all membranes. The majority of CD68+ monocytes/macrophages co-expressed the M2 macrophage marker CD206. In epiretinal membranes, cells undergoing MMT were identified by co-expression of the macrophage marker CD68 and myofibroblast markers α-SMA and FSP-1. Further analysis revealed that CD206+ M2 macrophages co-expressed α-SMA, FSP-1, FAP-α and ß-catenin. Soluble (s) CD206 and sFAP-α levels were significantly higher in vitreous samples from PDR and PVR patients than in nondiabetic control patients. The proinflammatory cytokine TNF-α and the hypoxia mimetic agent cobalt chloride induced upregulation of sFAP-α in culture media of Müller cells but not of HRMECs. The NF-ĸß inhibitor BAY11-7085 significantly attenuated TNF-α-induced upregulation of sFAP-α in Müller cells. Our findings suggest that the process of MMT might contribute to myofibroblast formation in epiretinal membranes, and this transition involved macrophages with a predominant M2 phenotype. In addition, sFAP-α as a vitreous biomarker may be derived from M2 macrophages transitioned to myofibroblasts and from Müller cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epiretinal MembraneEye DiseasesDiabetic RetinopathyVitreoretinopathy, ProliferativeHumansEndothelial CellsMyofibroblastsTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

M2 macrophagesmacrophage-myofibroblast transitionproliferative diabetic retinopathyproliferative vitreoretinopathy

Substanzen

Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
  • Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
  • Laboratory of Histochemistry and Cytochemistry, University of Leuven, KU Leuven, 3000 Leuven, Belgium.
  • University Hospitals UZ Gasthuisberg, 3000 Leuven, Belgium.
  • Laboratory of Molecular Immunology, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, University of Leuven, KU Leuven, 3000 Leuven, Belgium.
  • Laboratory of Immunobiology, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, University of Leuven, KU Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Ahmed M Abu El-Asrar, Mohd I Nawaz, Sara Abouelasrar Salama, Ghislain Opdenakker, Sofie Struyf

Förderung

  • Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
  • C1 funding
  • Research Foundation of Flanders
  • FWO-Vlaanderen

Zitieren

APA

Abu El-Asrar, A. M., De Hertogh, G., Allegaert, E., Nawaz, M. I., Abouelasrar Salama, S., Gikandi, P. W., Opdenakker, G., & Struyf, S. (2023). Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders. International Journal of Molecular Sciences, 24(17), 13510. https://doi.org/10.3390/ijms241713510

Vancouver

Abu El-Asrar AM, De Hertogh G, Allegaert E, Nawaz MI, Abouelasrar Salama S, Gikandi PW, et al. Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders. International Journal of Molecular Sciences. 2023;24(17):13510. doi:10.3390/ijms241713510

BibTeX
@article{AbuElAsrar2023,
  author = {Abu El-Asrar, Ahmed M and De Hertogh, Gert and Allegaert, Eef and Nawaz, Mohd I and Abouelasrar Salama, Sara and Gikandi, Priscilla W and Opdenakker, Ghislain and Struyf, Sofie},
  title = {Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {17},
  pages = {13510},
  doi = {10.3390/ijms241713510}
}
Kostenlos starten →